Skip to main content
Top
Published in: Child's Nervous System 1/2021

01-01-2021 | Cerebral Sinus Venous Thrombosis | Original Article

Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis

Authors: Ilaria Lazzareschi, Antonietta Curatola, Antonio Gatto, Filomena Maellaro, Paolo Frassanito, Maria Basso, Raimondo De Cristofaro, Piero Valentini

Published in: Child's Nervous System | Issue 1/2021

Login to get access

Abstract

Purpose

Cerebral venous thrombosis (CVT) is a rare disease in children, characterized by partial or total occlusion of blood flow in the cerebral venous system. The aim of this study is to describe clinical presentation, neuroimaging features, therapeutic management, and outcome of children with CVT.

Methods

We retrospectively analyzed the data, including clinical manifestations, laboratory data, neurological findings, and treatment of children with radiologically confirmed CVT, admitted between January 2010 and March 2020 to our hospital. Cases of CVT complicating brain surgery were excluded.

Results

We enrolled 24 children with CVT. Infection was the main etiology (58.3%), followed by trauma in 16.7% of cases. In the remaining 25% of cases, the cause was identified only in one patient presenting a thrombophilic factor. The most frequent site of thrombosis was the superficial venous system (86.8%), with multiple localizations disclosed in 79% of patients. All children received anticoagulant therapy with low molecular weight heparin (LMWH). One patient died for systemic complications of an underlying disease. No patient developed hemorrhagic events during the therapy, lasting from 35 to 360 days (mean 86 days). In all but one surviving patients (22 out of 24), recanalization of the sinus was observed at AngioMRI performed during follow-up. No neurological complications of CVT were recorded (mean follow-up: 1.5 year).

Conclusions

CVT may present with subtle and unspecific clinical manifestations in children. High level of suspicion should be kept in trauma and sinusitis. Anticoagulation treatment is safe and effective and should be promptly started to improve outcome.
Literature
1.
go back to reference Barnes C, Newall F, Furmedge J, Mackay M, Monagle P (2004) Cerebral sinus venous thrombosis in children. J Paediatr Child Health 40:53–55CrossRef Barnes C, Newall F, Furmedge J, Mackay M, Monagle P (2004) Cerebral sinus venous thrombosis in children. J Paediatr Child Health 40:53–55CrossRef
2.
go back to reference De Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ et al (2001) Cerebral sinovenous thrombosis in children. N Engl J Med 345:417–423CrossRef De Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ et al (2001) Cerebral sinovenous thrombosis in children. N Engl J Med 345:417–423CrossRef
3.
4.
go back to reference Witmer CM, Takemoto CM (2017) Pediatric hospital acquired venous thromboembolism. Front Pediatr 5:198CrossRef Witmer CM, Takemoto CM (2017) Pediatric hospital acquired venous thromboembolism. Front Pediatr 5:198CrossRef
5.
go back to reference Gao L, Xu W, Yu X, Cao S, Xu H, Yan F et al (2018) Accuracy of magnetic resonance venography in diagnosing cerebral venous sinus thrombosis. Thromb Res 167:64–73CrossRef Gao L, Xu W, Yu X, Cao S, Xu H, Yan F et al (2018) Accuracy of magnetic resonance venography in diagnosing cerebral venous sinus thrombosis. Thromb Res 167:64–73CrossRef
6.
go back to reference Widjaja E, Griffiths PD (2004) Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol 25:1557–1562PubMed Widjaja E, Griffiths PD (2004) Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol 25:1557–1562PubMed
7.
go back to reference Karsy M, Harmer JR, Guan J, Brock A, Ravindra VM, Chung LS et al (2018) Outcomes in adults with cerebral venous sinus thrombosis: a retrospective cohort study. J Clin Neurosci 53:34–40CrossRef Karsy M, Harmer JR, Guan J, Brock A, Ravindra VM, Chung LS et al (2018) Outcomes in adults with cerebral venous sinus thrombosis: a retrospective cohort study. J Clin Neurosci 53:34–40CrossRef
8.
go back to reference Wang Y, Meng R, Duan J, Liu G, Chen J, Li S et al (2016) Nephrotic syndrome may be one of the important etiologies of cerebral venous sinus thrombosis. J Stroke Cerebrovasc Dis 25:2415–2422CrossRef Wang Y, Meng R, Duan J, Liu G, Chen J, Li S et al (2016) Nephrotic syndrome may be one of the important etiologies of cerebral venous sinus thrombosis. J Stroke Cerebrovasc Dis 25:2415–2422CrossRef
9.
go back to reference Slasky SE, Rivaud Y, Suberlak M, Tairu O, Fox AD, Ohman-Strickland P (2017) Venous sinus thrombosis in blunt trauma: incidence and risk factors. J Comput Assist Tomogr 41:891–897CrossRef Slasky SE, Rivaud Y, Suberlak M, Tairu O, Fox AD, Ohman-Strickland P (2017) Venous sinus thrombosis in blunt trauma: incidence and risk factors. J Comput Assist Tomogr 41:891–897CrossRef
10.
go back to reference Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U et al (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e737S–e801SCrossRef Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U et al (2012) Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e737S–e801SCrossRef
11.
go back to reference Członkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2006) Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29:243–256CrossRef Członkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2006) Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 29:243–256CrossRef
12.
go back to reference Golomb M, Fullerton H, Nowak-Gottl U, Deveber G, International Pediatric Stroke Study Group (2009) Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40:52–57CrossRef Golomb M, Fullerton H, Nowak-Gottl U, Deveber G, International Pediatric Stroke Study Group (2009) Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke 40:52–57CrossRef
13.
go back to reference Ichord R, Benedict S, Chan A, Kirkham FJ, Nowak-Göttl U, International Paediatric Stroke Study Group (2015) Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child 100:174–179CrossRef Ichord R, Benedict S, Chan A, Kirkham FJ, Nowak-Göttl U, International Paediatric Stroke Study Group (2015) Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child 100:174–179CrossRef
14.
15.
go back to reference Jordan L, Rafay M, Smith S, Askalan R, Zamel KM, deVeber G et al (2010) Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr 156:704–710CrossRef Jordan L, Rafay M, Smith S, Askalan R, Zamel KM, deVeber G et al (2010) Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr 156:704–710CrossRef
16.
go back to reference Dlamini N, Billinghurst L, Kirkham FJ (2010) Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 21:511–527CrossRef Dlamini N, Billinghurst L, Kirkham FJ (2010) Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am 21:511–527CrossRef
17.
go back to reference Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators ISCVT (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670CrossRef Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators ISCVT (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670CrossRef
18.
go back to reference Qu H, Yang M (2013) Early imaging characteristics of 62 cases of cerebral venous sinus thrombosis. Exp Ther Med 5:233–236CrossRef Qu H, Yang M (2013) Early imaging characteristics of 62 cases of cerebral venous sinus thrombosis. Exp Ther Med 5:233–236CrossRef
19.
go back to reference Einhaupl KM, Villringer A, Meister W, Garner C, Pellkofer M, Haberl RL et al (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597–600CrossRef Einhaupl KM, Villringer A, Meister W, Garner C, Pellkofer M, Haberl RL et al (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597–600CrossRef
20.
go back to reference De Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484–488CrossRef De Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484–488CrossRef
21.
go back to reference Monagle P, Cuello C, Augustine C, Bonduel M, Brandão LR, Capman T et al (2018) American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2:3292–3316CrossRef Monagle P, Cuello C, Augustine C, Bonduel M, Brandão LR, Capman T et al (2018) American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2:3292–3316CrossRef
22.
go back to reference Newall F, Branchford B, Male C (2018) Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J Thromb Haemost 16:196–208CrossRef Newall F, Branchford B, Male C (2018) Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. J Thromb Haemost 16:196–208CrossRef
23.
go back to reference Greene LALC, Law C, Jung M, Walton S, Ignjatovic V, Monagle P et al (2014) Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 12:1554–1557CrossRef Greene LALC, Law C, Jung M, Walton S, Ignjatovic V, Monagle P et al (2014) Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 12:1554–1557CrossRef
24.
go back to reference Monagle P, Newall F (2018) Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program 2018:399–404CrossRef Monagle P, Newall F (2018) Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology Am Soc Hematol Educ Program 2018:399–404CrossRef
25.
go back to reference Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, SURVET Study Investigators et al (2015) Sulodexide for the prevention of recurrent venous thromboembolism: the Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation 132:1891–1897CrossRef Andreozzi GM, Bignamini AA, Davì G, Palareti G, Matuška J, Holý M, SURVET Study Investigators et al (2015) Sulodexide for the prevention of recurrent venous thromboembolism: the Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation 132:1891–1897CrossRef
26.
go back to reference Cohen O, Levy-Mendelovich S, Ageno W (2020) Rivaroxaban for the treatment of venous thromboembolism in pediatric patients. Expert Rev Cardiovasc Ther 24:1–9 Cohen O, Levy-Mendelovich S, Ageno W (2020) Rivaroxaban for the treatment of venous thromboembolism in pediatric patients. Expert Rev Cardiovasc Ther 24:1–9
27.
go back to reference Chhim RF, Shelton CM, Christensen ML (2013) Recent new drug approvals, part 2: drugs undergoing active clinical studies in children. J Pediatr Pharmacol Ther 18:14–38PubMedPubMedCentral Chhim RF, Shelton CM, Christensen ML (2013) Recent new drug approvals, part 2: drugs undergoing active clinical studies in children. J Pediatr Pharmacol Ther 18:14–38PubMedPubMedCentral
28.
go back to reference Male C, Lensing AWA, Palumbo JS et al (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol 7:e18–e27CrossRef Male C, Lensing AWA, Palumbo JS et al (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol 7:e18–e27CrossRef
Metadata
Title
Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis
Authors
Ilaria Lazzareschi
Antonietta Curatola
Antonio Gatto
Filomena Maellaro
Paolo Frassanito
Maria Basso
Raimondo De Cristofaro
Piero Valentini
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 1/2021
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-020-04958-z

Other articles of this Issue 1/2021

Child's Nervous System 1/2021 Go to the issue